+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Nicotine Replacement Therapy, E-cigarettes, Heat-not-burn Tobacco Products), Distribution Channel (Online, Offline), Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 82 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5265095
Description Jump to:
The global nicotine replacement therapy market size is expected to reach USD 198.7 billion by 2030, according to the report. It is expected to grow at a CAGR of 16.3% from 2023 to 2030. The growth of the market is largely attributed to increasing government initiatives to promote nicotine replacement therapy (NRT) products for reducing mortality due to smoking and diseases associated with it.

Smoking cessation campaigns are also playing a crucial role in increasing awareness about diseases that are caused because of smoking. These campaigns are run by regional governments as well as multinational companies, such as Philip Morris International and Altria. Global organizations like the WHO are also working toward creating awareness by running online campaigns.

There has been an exponential increase in the usage of NRT products. The young population is the largest consumer of advanced NRT products, like heat-not-burn tobacco and e-cigarettes. However, middle-aged patients’ interest in smoking cessation has led to a rise in the usage of e-cigarettes. For instance, the use of e-cigarettes for smoking cessation increased to 20% in 2018 from 13% in 2016 among people aged 45 to 54 years.

Furthermore, researchers found that 5% to 9% of smokers tend to use nicotine patches even after the therapeutic period of 12 weeks. The passive approach of combining nicotine patches with a gum, inhaler, or spray is found to be more effective, and quitting rate reaching 34% to 54%. NRT is only recognized as a way of curbing nicotine cravings and treatment by consumers.

With technological advancements, the players in this market are also developing products to suit the changing consumer preferences. For instance, the e-cigarette market is changing with newer innovations that are more efficient, have longer battery life, and are rechargeable. The existing innovations like sleek and easy-to-use socially acceptable e-cigarettes brought a revolution, which drove more people to shift to using NRTs without social stigma.

Various players such as Nicocigs Ltd.; Nicoventures Ltd.; Victory Electronic Cigarettes Corp.; DuraSmoke; AlternaCig; Shenzhen IVPS Technology CO. Limited; and Vapor Group, Inc. are launching e-cigarettes and related products. Although there are hundreds of companies selling e-cigarettes, their usage in NRT is disputed.

Nicotine Replacement Therapy Market Report Highlights

  • By product, the e-cigarettes segment held the largest NRT market share in 2022 due to increasing investments and the rising focus of companies on developing value-added products. The heat-not-burn tobacco products segment is expected to grow at the fastest rate over the forecast period
  • The offline distribution channel segment dominated the market in 2022. Retail chains across the world are investing in advanced technologies and undertaking new initiatives in order to improve sales and attract more customers. The increasing sales of e-cigarettes through vape shops and retail stores is another factor augmenting the growth of this segment
  • Asia Pacific held the largest market share in 2022. Favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products, are supporting continual growth

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Distribution channel
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Distribution channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Nicotine Replacement Therapy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Nicotine Replacement Therapy Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Pediatric Catheters: Product Estimates & Trend Analysis
4.1. Nicotine Replacement Therapy Market: Key Takeaways
4.2. Nicotine Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Nicotine Replacement Therapy
4.3.1. Nicotine replacement therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Inhalers
4.3.2.1. Inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Gum
4.3.3.1. Gum market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Transdermal patches
4.3.4.1. Transdermal patches market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. Sublingual tablets
4.3.5.1. Sublingual tablets market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6. Lozenges
4.3.6.1. Lozenges market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.7. Others
4.3.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. E-cigarettes
4.4.1. E-cigarettes market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Heat-not-burn tobacco products
4.5.1. Heat-not-burn tobacco products market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Pediatric Catheters: Distribution Channel Estimates & Trend Analysis
5.1. Nicotine Replacement Therapy Market: Key Takeaways
5.2. Nicotine Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Online
5.3.1. Online market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Offline
5.4.1. Offline market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Nicotine Replacement Therapy Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Nicotine Replacement Therapy Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. UK
6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. Germany
6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. France
6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Italy
6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Spain
6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Sweden
6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Norway
6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.9. Denmark
6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. Japan
6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. China
6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. India
6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Australia
6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. Thailand
6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.7. South Korea
6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Brazil
6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Mexico
6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.4. Argentina
6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. South Africa
6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. UAE
6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.5. Kuwait
6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Cipla Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Pfizer Inc.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. GLENMARK PHARMACEUTICALS LTD.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Fertin Pharma
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Philip Morris Products S.A.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. British American Tobacco plc
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Japan Tobacco Inc.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Imperial Brands plc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Johnson & Johnson Private Limited
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America nicotine replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 3 North America nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 4 North America nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 5 U.S. nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Canada nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 8 Canada nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 Europe nicotine replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 10 Europe nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 11 Europe nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 12 Germany nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 13 Germany nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 14 UK nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 15 UK nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 France nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 17 France nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 18 Italy nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 19 Italy nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Spain nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 21 Spain nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 Sweden nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 23 Sweden nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 Norway nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 25 Norway nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 26 Denmark nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 27 Denmark nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 Asia Pacific nicotine replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 30 Asia Pacific nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 31 China nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 32 China nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 33 Japan nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 34 Japan nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 35 India nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 36 India nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 37 Australia nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 38 Australia nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 39 Thailand nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 41 South Korea nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 43 Latin America nicotine replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 45 Latin America nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 46 Brazil nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 48 Mexico nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Argentina nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa nicotine replacement therapy market, by region, (USD Million) 2018 -2030
Table 53 Middle East and Africa nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 55 South Africa nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 59 UAE nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 60 UAE nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 Kuwait nicotine replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait nicotine replacement therapy market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Pediatric catheters: market outlook
Fig. 9 Pediatric catheters competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Nicotine replacement therapy market driver impact
Fig. 14 Nicotine replacement therapy market restraint impact
Fig. 15 Nicotine replacement therapy market strategic initiatives analysis
Fig. 16 Nicotine replacement therapy market: Product movement analysis
Fig. 17 Nicotine replacement therapy market: Product outlook and key takeaways
Fig. 18 Nicotine replacement therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Gum market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Transdermal patches market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Sublingual tablets market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Lozenges market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 E-cigarettes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Heat-not-burn tobacco products market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Nicotine replacement therapy market: Distribution channel movement analysis
Fig. 28 Nicotine replacement therapy market: Distribution channel outlook and key takeaways
Fig. 29 Online market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Offline market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Nicotine replacement therapy market: Regional movement analysis
Fig. 32 Nicotine replacement therapy market: Regional outlook and key takeaways
Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Profiled

  • Cipla Inc.
  • Pfizer Inc.
  • GLENMARK PHARMACEUTICALS LTD.
  • Fertin Pharma
  • Philip Morris Products S.A.
  • British American Tobacco plc
  • Japan Tobacco Inc.
  • Imperial Brands plc
  • Johnson & Johnson Private Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages82
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 59.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 198.7 Billion
Compound Annual Growth Rate16.3%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Australia Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Nicotine Replacement Therapy, E-Cigarettes), Distribution Channel (Online, Offline), and Segment Forecasts, 2024-2030 - Product Image

Australia Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Nicotine Replacement Therapy, E-Cigarettes), Distribution Channel (Online, Offline), and Segment Forecasts, 2024-2030

  • Report
  • 119 Pages
  • Australia
From
Nicotine Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Nicotine Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Nicotine Replacement Therapy Global Market Report 2024 - Product Image

Nicotine Replacement Therapy Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Nicotine Replacement Therapy Products Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Nicotine Replacement Therapy Products Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 101 Pages
  • Global
From
India Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Gums, Lozenges), Strength (2 mg, 4 mg), Distribution Channel (Online, Offline, Hospital Pharmacies, Retail Pharmacies), and Segment Forecasts, 2024-2030 - Product Image

India Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Gums, Lozenges), Strength (2 mg, 4 mg), Distribution Channel (Online, Offline, Hospital Pharmacies, Retail Pharmacies), and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • India
From

About the Market

The Nicotine Replacement Therapy (NRT) market is a subset of the Over the Counter (OTC) Drugs market. NRT products are designed to help people quit smoking by providing a safe and effective way to reduce nicotine cravings. These products come in a variety of forms, including patches, gum, lozenges, inhalers, and sprays. NRT products are available without a prescription and are often used in combination with other smoking cessation methods, such as counseling and support groups. NRT products are widely available in pharmacies, supermarkets, and other retail outlets. They are also available online, making them accessible to a wider range of consumers. NRT products are generally considered safe and effective, and they are often recommended by healthcare professionals as part of a comprehensive smoking cessation plan. Some companies in the NRT market include GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Perrigo. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.